Vertex Pharmaceuticals Incorporated (LON:0QZU)
London
· Delayed Price · Currency is GBP · Price in USD 499.74
-3.28 (-0.65%)
Mar 28, 2025, 7:21 PM BST
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 97.73 billion as of March 31, 2025. Its market cap has increased by 17.19% in one year.
Market Cap
97.73B
Enterprise Value
90.41B
Revenue
8.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
499.74
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 97.73B, an increase of 190,738.48%. That is a compound annual growth rate of 25.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.02B |
| GSK plc | 60.68B |
| Haleon | 35.23B |
| Smith & Nephew | 9.36B |
| ConvaTec Group | 5.28B |
| Hikma Pharmaceuticals | 4.33B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.24B |